V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310004454 | 310001947 | 1.7 | 54 | Palliative (P) | 2014-01-03 | 2014-01-10 | Mitomycin Intravesical | N | N | 310019880 | DACARBAZINE |
| 310004455 | 310006832 | 1.81 | null | null | 2014-11-01 | 2014-11-23 | EOX | N | N | 310019886 | RITUXIMAB |
| 310004456 | 310009182 | null | null | null | null | 2016-12-08 | Hydroxycarbamide | N | N | 310019887 | LIPOSOMAL DOXORUBICIN |
| 310004457 | 310001948 | 1.64 | 75.2 | Neo-adjuvant (N) | 2015-08-20 | 2015-08-20 | Bevacizumab+Carbo+Pacliaxel | N | N | 310019889 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310004458 | 310001949 | 1.66 | 77.7 | Disease modification (D) | 2016-07-26 | 2016-07-26 | CISPLATIN + FLUOROURACIL | N | N | 310019890 | CAPECITABINE + OXALIPLATIN |
| 310004459 | 310001950 | 1.61 | 62.6 | Disease modification (D) | 2014-01-22 | 2014-01-31 | Liposomal Doxorubicin (Caelyx) | N | N | 310019891 | GEMCITABINE + PACLITAXEL |
| 310004460 | 310001951 | 1.68 | 73.35 | Curative (C) | 2015-11-25 | 2015-12-06 | ICON8 TRIAL | N | N | 310019894 | HYDROXYCARBAMIDE |
| 310004462 | 310001953 | 1.81 | 80.2 | null | 2017-02-13 | 2017-03-16 | Capecitabine + Cisplatin | N | N | 310019897 | DACARBAZINE |
| 310004463 | 310001954 | 1.79 | 19 | Palliative (P) | null | 2017-05-16 | IPILIMUMAB + NIVOLUMAB | N | N | 310019898 | IPILIMUMAB + NIVOLUMAB |
| 310004464 | 310001955 | 1.61 | 70 | Adjuvant (A) | null | 2016-10-20 | GEMCITABINE | N | N | 310019900 | GEMCITABINE |
| 310004465 | 310001956 | null | 71.1 | Palliative (P) | 2016-12-24 | 2016-12-24 | null | 2 | null | 310019901 | NOT MATCHED |
| 310004466 | 310006833 | 1.8 | 82.4 | Palliative (P) | 2017-06-06 | 2017-06-08 | Bexarotene | N | N | 310019902 | CAPECITABINE |
| 310004467 | 310006833 | null | 72 | Neo-adjuvant (N) | 2016-09-01 | 2016-09-01 | Mitomycin Intravesical | 02 | N | 310019902 | BCG |
| 310004468 | 310006833 | 1.62 | 72.1 | Palliative (P) | 2016-08-26 | 2016-08-28 | Capecitabine + Cisplatin | N | N | 310019902 | CISPLATIN + FLUOROURACIL |
| 310004469 | 310006833 | 1.59 | null | Disease modification (D) | 2016-03-05 | 2016-03-06 | ICON8 TRIAL | Y | null | 310019902 | PACLITAXEL |
| 310004470 | 310001957 | 1.68 | 100.3 | Palliative (P) | 2014-10-08 | 2014-10-22 | NB Low/Interm risk guidelines Carbo/Etop | N | N | 310019913 | NOT MATCHED |
| 310004471 | 310006834 | null | null | null | null | 2013-09-16 | Hydroxycarbamide | 01 | null | 310019916 | EOX |
| 310004472 | 310006834 | 0 | 74 | Curative (C) | 2015-06-04 | 2015-06-06 | CHOEP - 21 days | 2 | N | 310019916 | CHOEP |
| 310004473 | 310006834 | 1.81 | 80 | Curative (C) | 2017-02-14 | 2017-02-14 | CAPECITABINE + OXALIPLATIN | N | N | 310019916 | HYDROXYCARBAMIDE |
| 310004474 | 310006834 | 1.56 | 77.5 | null | 2016-04-28 | 2016-04-28 | EOX | N | N | 310019916 | HYDROXYCARBAMIDE |
| 310004475 | 310011461 | 0 | 76.2 | Palliative (P) | 2013-07-27 | 2013-07-27 | IPILIMUMAB + NIVOLUMAB | 2 | N | 310019928 | IPILIMUMAB + NIVOLUMAB |
| 310004476 | 310001958 | 1.68 | 0 | Disease modification (D) | 2015-06-19 | 2015-06-20 | Dacarbazine | null | null | 310019931 | DACARBAZINE |
| 310004477 | 310001959 | 1.74 | 66.4 | Palliative (P) | 2018-07-06 | 2018-07-20 | Cisplatin +Fluorouracil (3 wk) | N | N | 310019932 | EOX |
| 310004478 | 310001960 | null | null | Disease modification (D) | 2017-08-11 | 2017-08-14 | ECX | 02 | N | 310019936 | DACARBAZINE |
| 310004479 | 310001960 | 1.69 | 68.4 | Palliative (P) | 2014-09-05 | 2014-09-05 | Oxaliplatin + Modified de Gramont | N | N | 310019936 | EOX |
| 310004480 | 310001961 | 1.73 | 69.2 | Palliative (P) | 2018-02-07 | 2018-02-07 | IMATINIB | 2 | Y | 310019942 | CAPECITABINE + OXALIPLATIN |
| 310004481 | 310001962 | null | 100.7 | Palliative (P) | 2014-07-02 | 2014-08-19 | EOX | 02 | null | 310019946 | IMATINIB |
| 310004482 | 310001963 | 1.78 | 46.1 | Palliative (P) | 2014-12-18 | 2014-12-30 | IPILIMUMAB + NIVOLUMAB | 2 | N | 310019947 | HYDROXYCARBAMIDE |
| 310004483 | 310001964 | null | 56.4 | Palliative (P) | 2014-06-22 | 2014-07-04 | IMATINIB | N | N | 310019949 | CAPECITABINE + OXALIPLATIN |
| 310004484 | 310001965 | 1.59 | null | Disease modification (D) | 2017-08-26 | 2017-08-26 | Gemcitabine weekly | N | N | 310019950 | GEMCITABINE |
| 310004485 | 310001966 | 1.8 | 76 | Adjuvant (A) | null | 2014-08-10 | ECX | 02 | N | 310019951 | ECX |
| 310004486 | 310001966 | 1.68 | 0 | Palliative (P) | 2016-12-28 | 2016-12-28 | Rituximab | 2 | N | 310019951 | RITUXIMAB |
| 310004487 | 310001966 | 1.83 | 88.2 | Curative (C) | 2017-05-09 | 2017-05-13 | CHOEP - 21 days | Y | N | 310019951 | CHOEP |
| 310004488 | 310001966 | null | 76 | Neo-adjuvant (N) | 2014-02-27 | 2014-02-27 | Bevacizumab+Carbo+Pacliaxel | N | N | 310019951 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310004489 | 310001967 | 1.78 | null | Palliative (P) | 2014-01-01 | 2014-01-06 | IPILIMUMAB + NIVOLUMAB | N | null | 310019955 | IPILIMUMAB + NIVOLUMAB |
| 310004490 | 310001968 | 1.7 | 83.9 | Palliative (P) | 2014-02-24 | 2014-03-10 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 310019956 | GEMCITABINE |
| 310004491 | 310006837 | 1.71 | null | Neo-adjuvant (N) | 2014-01-19 | 2014-01-24 | Vemurafenib | N | null | 310019958 | CAPECITABINE + OXALIPLATIN |
| 310004492 | 310009186 | 1.86 | null | Palliative (P) | 2016-04-08 | 2015-10-30 | ICON8 TRIAL | N | N | 310019959 | OXALIPLATIN + MDG |
| 310004493 | 310009186 | 1.72 | 70.6 | Palliative (P) | 2016-02-21 | 2016-02-21 | IPILIMUMAB + NIVOLUMAB | 02 | null | 310019959 | IPILIMUMAB + NIVOLUMAB |
| 310004495 | 310001970 | -1 | 40.9 | Disease modification (D) | 2016-08-25 | 2016-08-28 | Oxaliplatin + Modified de Gramont | 02 | N | 310019962 | MITOMYCIN INTRAVESICULAR |
| 310004496 | 310001971 | 1.59 | 77 | Palliative (P) | 2016-05-24 | 2016-06-22 | CISPLATIN + FLUOROURACIL | 99 | N | 310019963 | CISPLATIN + FLUOROURACIL |
| 310004497 | 310001972 | 1.75 | null | Curative (C) | 2013-11-02 | 2013-11-04 | EOX | N | null | 310019969 | HYDROXYCARBAMIDE |
| 310004498 | 310001972 | 1.62 | 55.4 | Palliative (P) | 2014-08-31 | 2014-09-15 | ECX | 02 | N | 310019969 | ECX |
| 310004499 | 310001973 | 1.6 | 62 | Palliative (P) | 2015-08-13 | 2015-09-12 | BCG Intravesical | N | N | 310019971 | RITUXIMAB |
| 310004500 | 310001974 | 0 | 104 | Curative (C) | 2016-08-19 | 2016-09-06 | CHOEP | 02 | N | 310019974 | CHOEP |
| 310004501 | 310001975 | 1.79 | null | Neo-adjuvant (N) | null | 2016-12-20 | ECX | 02 | N | 310019977 | ECX |
| 310004502 | 310001975 | 1.71 | 68.4 | Disease modification (D) | 2013-02-21 | 2013-02-28 | Hydroxycarbamide | 02 | N | 310019977 | IMATINIB |
| 310004503 | 310001975 | 1.71 | 0 | Palliative (P) | null | 2014-08-22 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310019977 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310004504 | 310001976 | 1.82 | 82.6 | Neo-adjuvant (N) | null | 2015-05-10 | Capecitabine + Oxaliplatin 21day | Y | N | 310019980 | BEXAROTENE |
| 310004505 | 310001977 | 1.75 | 120.5 | null | 2014-05-15 | 2014-05-17 | Liposomal Doxorubicin (Caelyx) | N | N | 310019981 | BEXAROTENE |